Albuminuria in heart failure: what do we really know?

@article{Dobre2009AlbuminuriaIH,
  title={Albuminuria in heart failure: what do we really know?},
  author={Daniela Dobre and Sandeep Nimade and Dick de Zeeuw},
  journal={Current Opinion in Cardiology},
  year={2009},
  volume={24},
  pages={148–154}
}
Purpose of the review To describe the role of albuminuria as a risk marker for heart failure and a predictor for treatment effect on heart failure prognosis. Recent findings The level of albumin in the urine is a predictor of heart failure in the general population and in patients with cardiovascular risk, such as those with diabetes. Mild elevations of albuminuria, in the microalbuminuria range, appear to be associated with impaired systemic endothelial function. This increases the chance of… Expand
Albuminuria: Associated With Heart Failure Severity and Impaired Clinical Outcomes.
TLDR
Albuminuria provides important information regarding several detrimental processes in HF and is a significant predictor of a worse outcome. Expand
High-normal albuminuria and risk of heart failure in the community.
TLDR
The results suggest that the association between albuminuria and heart failure may not be mediated fully by ischemic heart disease or kidney disease, measured using eGFR. Expand
Body Mass Index or Microalbuminuria, Which One is More Important for the Prediction and Prevention of Diastolic Dysfunction in Non-diabetic Hypertensive Patients?
TLDR
Obesity is more important than microalbuminuria for the prediction and prevention of diastolic dysfunction in non-diabetic hypertensive patients, according to this investigation. Expand
Albuminuria and left ventricular mass index are associated with left ventricular diastolic dysfunction in type 2 diabetes mellitus patients
TLDR
This study reveals a high incidence of LVDD in asymptomatic type 2 DM patients and, this finding was correlated with age, sex, LVMI and albuminuria. Expand
Predictors of Incident Heart Failure Hospitalizations Among Patients With Impaired Glucose ToleranceClinical Perspective
TLDR
Among research participants with impaired glucose tolerance, there are several easily identifiable predictors of incident HF hospitalization, including traditional risk factors and novel indices of central adiposity and increased urinary albumin–creatinine ratio, which enable further risk stratification and help distinguish patients who could benefit from more aggressive risk factor management. Expand
Correlation of brain natriuretic peptide and microalbuminuria in patients with heart failure.
TLDR
Both NT-proBNP and MAU levels were closely associated with the severity of heart failure and the correlation between them was high. Expand
Adding thiazide to a rennin-angiotensin blocker regimen to improve left ventricular relaxation in diabetes and nondiabetes patients with hypertension
TLDR
Improvement in LV diastolic function is associated with an improvement of DM and a concomitant reduction in UACR among DM patients, and with a reduction of hs-CRP in patients without DM when thiazide is added to a renin–angiotensin blocker treatment regimen. Expand
Correlation of Microalbuminuria and Multiple Risk Factors in Acute Coronary Syndrome
Background: The current study was undertaken at tertiary care center, Bhopal, MP, Central India. with the objective is to study the occurrence of microalbuminuria in acute coronary syndrome and toExpand
Predictors of Incident Heart Failure Hospitalizations Among Patients With Impaired Glucose Tolerance: Insight From the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Study
TLDR
Among research participants with impaired glucose tolerance, there are several easily identifiable predictors of incident HF hospitalization, including traditional risk factors and novel indices of central adiposity and increased urinary albumin–creatinine ratio, which enable further risk stratification and help distinguish patients who could benefit from more aggressive risk factor management. Expand
The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction
TLDR
Evaluated the associations of CKD and microalbuminuria with incident HF subtypes in the community‐based Framingham Heart Study (FHS), finding associations with preserved vs. reduced EF are unknown. Expand
...
1
2
...

References

SHOWING 1-10 OF 61 REFERENCES
High prevalence of microalbuminuria in chronic heart failure patients.
TLDR
The prevalence of microalbuminuria and the association with neurohormonal parameters in severe chronic heart failure patients receiving therapy with angiotensin-converting enzyme (ACE) inhibitors was evaluated and correlated with urinary albumin/creatinine ratio. Expand
Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study
TLDR
This large prospective study of hypertensive patients with left ventricular hypertrophy found that increasing albuminuria is associated with a graded increase in risk, and any threshold identified would be much lower than the threshold traditionally defined in diabetic populations. Expand
Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy
TLDR
Albuminuria is an important factor predicting cardiovascular risk in patients with type 2 diabetic nephropathy, and reducing albuminuria in the first 6 months appears to afford cardiovascular protection in these patients. Expand
Microalbuminuria in systolic and diastolic chronic heart failure patients.
TLDR
In systolic HF patients microalbuminuria was associated with factors known to be markers of worse prognosis, and in the diastolic HF group, the presence of microalbum inuria was not associated with any known risk factor. Expand
Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes.
TLDR
Overt albuminuria predicts the occurrence of HF hospitalizations in type 2 diabetic patients and early aggressive treatment of diabetic nephropathy should be investigated as a means of preventing of HF. Expand
Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study.
TLDR
Albuminuria is independently associated with LV systolic and diastolic dysfunction in type 2 DM; this may explain in part the relationship of albuminuria to increased cardiovascular (CV) events in the DM population. Expand
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.
TLDR
The results indicate that any degree of albuminuria is a risk factor for CV events in individuals with or without DM; the risk increases with the ACR, starting well below the microalbuminuria cutoff. Expand
Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study
TLDR
Ramipril significantly reduces the rate of development of heart failure in patients at high risk of cardiovascular events. Expand
Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction.
TLDR
Clinical proteinuria is an independent predictor of hospitalization for CHF and mortality in diabetic and nondiabetic patients with left ventricular dysfunction and enalapril significantly reduces the risk of clinical proteinuria in diabetic patients with LV dysfunction. Expand
Arterial hypertension, microalbuminuria, and risk of ischemic heart disease.
TLDR
Urinary albumin excretion should be measured regularly in a hypertension clinic, and a rigorous control of blood pressure and of other atherosclerotic risk factors is recommended in hypertensive patients with microalbuminuria. Expand
...
1
2
3
4
5
...